Immucell Corp ICCC
Key Stats
- Today's Range
- $10.05 – $10.49
- 50-Day Range
- $9.25 – $12.10
- 52-Week Range
- $4.52 – $12.10
- Volume
- 11K shs
- Average Volume
- 31K shs
- Market Cap
- $91.37 million
- P/E Ratio
- 143.71
- Dividend Yield
- —
Valuation
- P/E Ratio
- 143.71
- Price / Book
- 2.91
- Price / Sales
- 2.98
Short Interest
- Short Interest
- 0.20%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $30.68 million
- Net Income
- $787,373
- Net Margin
- 2.57%
- Return on Equity
- 2.51%
- Debt-to-Equity
- 0.26
About Immucell Corp
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Related Stocks
Compare head-to-head: ICCC vs IDXX·ICCC vs LNTH·ICCC vs CLDX·ICCC vs NTLA
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.